Breaking News
Loading...
Thursday, January 28, 2016
» » Cancer 9th post

Cancer 9th post

January 28, 2016

Continued List of Serials

  1.  Thomsen A, Kolesar JM (December 2008). "Chemoprevention of breast cancer". Am J Health Syst Pharm 65 (23): 2221–8. doi:10.2146/ajhp070663.PMID 19020189.
  2. Jump up^ Wilt TJ, MacDonald R, Hagerty K, Schellhammer P, Kramer BS (2008). Wilt, Timothy J, ed. "Five-alpha-reductase Inhibitors for prostate cancer prevention".Cochrane Database Syst Rev (2): CD007091.doi:10.1002/14651858.CD007091. PMID 18425978.
  3. Jump up^ "Vitamins and minerals: not for cancer or cardiovascular prevention". Prescrire Int 19 (108): 182. August 2010.PMID 20939459.
  4. Jump up^ Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (April 2006). "Prospective study of predictors of vitamin D status and cancer incidence and mortality in men". J. Natl. Cancer Inst. 98 (7): 451–9.doi:10.1093/jnci/djj101. PMID 16595781.
  5. Jump up^ "Vitamin D Has Role in Colon Cancer Prevention". Archived from the original on 4 December 2006. Retrieved27 July 2007.[dead link]
  6. Jump up^ Schwartz GG, Blot WJ (April 2006). "Vitamin D status and cancer incidence and mortality: something new under the sun". J. Natl. Cancer Inst. 98 (7): 428–30.doi:10.1093/jnci/djj127. PMID 16595770.
  7. Jump up^ Fritz H, Kennedy D, Fergusson D, Fernandes R, Doucette S, Cooley K, Seely A, Sagar S, Wong R, Seely D (2011). Minna, John D, ed. "Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis". PLoS ONE 6 (6): e21107. Bibcode:2011PLoSO...6E1107F.doi:10.1371/journal.pone.0021107. PMC 3124481.PMID 21738614.
  8. Jump up^ Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER (June 2007). "Folic acid for the prevention of colorectal adenomas: a randomized clinical trial". JAMA 297 (21): 2351–9.doi:10.1001/jama.297.21.2351. PMID 17551129.
  9. Jump up^ Vinceti, M; Dennert, G; Crespi, CM; Zwahlen, M; Brinkman, M; Zeegers, MP; Horneber, M; D'Amico, R; Del Giovane, C (Mar 30, 2014). "Selenium for preventing cancer.". The Cochrane database of systematic reviews 3: CD005195. doi:10.1002/14651858.CD005195.pub3.PMID 24683040.
  10. ^ Jump up to:a b c "Cancer Vaccine Fact Sheet". NCI. 8 June 2006. Retrieved 15 November 2008.
  11. ^ Jump up to:a b Lertkhachonsuk AA, Yip CH, Khuhaprema T, Chen DS, Plummer M, Jee SH, Toi M, Wilailak S (2013). "Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013". Lancet Oncology 14 (12): e497–507. doi:10.1016/S1470-2045(13)70350-4.PMID 24176569.
  12. ^ Jump up to:a b c "What Is Cancer Screening?". National Cancer Institute.
  13. ^ Jump up to:a b c Wilson JMG, Jungner G. (1968) Principles and practice of screening for disease. Geneva:World Health Organization. Public Health Papers, #34.
  14. Jump up^ "Screening for Cervical Cancer". U.S. Preventive Services Task Force. 2003.
  15. Jump up^ "Screening for Colorectal Cancer". U.S. Preventive Services Task Force. 2008.
  16. Jump up^ "Screening for Skin Cancer". U.S. Preventive Services Task Force. 2009.
  17. Jump up^ "Screening for Oral Cancer". U.S. Preventive Services Task Force. 2004.
  18. Jump up^ "Lung Cancer Screening". U.S. Preventive Services Task Force. 2004.
  19. Jump up^ "Screening for Prostate Cancer". U.S. Preventive Services Task Force. 2008.
  20. Jump up^ "Screening for Bladder Cancer". U.S. Preventive Services Task Force. 2004.
  21. Jump up^ "Screening for Testicular Cancer". U.S. Preventive Services Task Force. 2004.
  22. Jump up^ "Screening for Ovarian Cancer". U.S. Preventive Services Task Force. 2004.
  23. Jump up^ "Screening for Pancreatic Cancer". U.S. Preventive Services Task Force. 2004.
  24. Jump up^ Chou, Roger; Croswell, Jennifer M.; Dana, Tracy; Bougatous, Christina; Blazina, Ian; Fu, Rongwei; Gleitsmann, Ken; Koenig, Helen C.; et al. (7 October 2011)."Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force". United States Preventive Services Task Force. Retrieved 8 October2011.
  25. Jump up^ "Screening for Breast Cancer". U.S. Preventive Services Task Force. 2009.
  26. Jump up^ Gøtzsche PC, Nielsen M (2011). Gøtzsche, Peter C, ed. "Screening for breast cancer with mammography". Cochrane Database Syst Rev (1): CD001877.doi:10.1002/14651858.CD001877.pub4.PMID 21249649.
  27. ^ Jump up to:a b Gulati AP, Domchek, SM (Jan 2008). "The clinical management of BRCA1 and BRCA2 mutation carriers".Current oncology reports 10 (1): 47–53. doi:10.1007/s11912-008-0008-9. PMID 18366960.
  28. Jump up^ Lind M.J., M.J. (2008). "Principles of cytotoxic chemotherapy". Medicine 36 (1): 19–23.doi:10.1016/j.mpmed.2007.10.003.
  29. Jump up^ National Cancer Institute (Dec 2012). "Targeted Cancer Therapies". www.cancer.gov. Retrieved 9 March 2014.
  30. Jump up^ NCI: Targeted Therapy tutorials Archived 4 October 2014 at the Wayback Machine
  31. ^ Jump up to:a b Holland Chp. 40
  32. Jump up^ Nastoupil, LJ; Rose, AC; Flowers, CR (May 2012). "Diffuse large B-cell lymphoma: current treatment approaches".Oncology (Williston Park, N.Y.) 26 (5): 488–95.PMID 22730604.
  33. Jump up^ Freedman, A (October 2012). "Follicular lymphoma: 2012 update on diagnosis and management". American journal of hematology 87 (10): 988–95. doi:10.1002/ajh.23313.PMID 23001911.
  34. Jump up^ Rampling, R; James, A; Papanastassiou, V (June 2004)."The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy". Journal of neurology, neurosurgery, and psychiatry. 75 Suppl 2 (Suppl 2): ii24–30. doi:10.1136/jnnp.2004.040535.PMC 1765659. PMID 15146036.
  35. Jump up^ Madan, V; Lear, JT; Szeimies, RM (February 20, 2010). "Non-melanoma skin cancer". Lancet 375 (9715): 673–85.doi:10.1016/S0140-6736(09)61196-X. PMID 20171403.
  36. Jump up^ CK Bomford, IH Kunkler, J Walter. Walter and Miller's Textbook of Radiation therapy (6th Ed), p311
  37. Jump up^ "Radiosensitivity" on GP notebookhttp://www.gpnotebook.co.uk/simplepage.cfm?ID=2060451853
  38. Jump up^ "Radiation therapy- what GPs need to know" on patient.co.uk http://www.patient.co.uk/showdoc/40002299/
  39. Jump up^ Hill, R; Healy, B; Holloway, L; Kuncic, Z; Thwaites, D; Baldock, C (21 March 2014). "Advances in kilovoltage x-ray beam dosimetry.". Physics in medicine and biology 59 (6): R183–231. doi:10.1088/0031-9155/59/6/r183.PMID 24584183.
  40. ^ Jump up to:a b Holland Chp. 41
  41. ^ Jump up to:a b c d e American Society of Clinical Oncology. "Five Things Physicians and Patients Should Question" (PDF).Choosing Wisely: an initiative of the ABIM Foundation(American Society of Clinical Oncology). RetrievedAugust 14, 2012
  42. Jump up^
    • The American Society of Clinical Oncology made this recommendation based on various cancers. SeeAmerican Society of Clinical Oncology. "Five Things Physicians and Patients Should Question" (PDF).Choosing Wisely: an initiative of the ABIM Foundation(American Society of Clinical Oncology). RetrievedAugust 14, 2012
    • for lung cancer, see Azzoli, CG; Temin, S; Aliff, T; Baker, S; Brahmer, J; Johnson, DH; Laskin, JL; Masters, G; Milton, D; Nordquist, L; Pao, W; Pfister, DG; Piantadosi, S; Schiller, JH; Smith, R; Smith, TJ; Strawn, JR; Trent, D; Giaccone, G; American Society of Clinical Oncology (2011). "2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer". Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29 (28): 3825–31.doi:10.1200/JCO.2010.34.2774. PMC 3675703.PMID 21900105. and Ettinger, DS; Akerley, W; Bepler, G; Blum, MG; Chang, A; Cheney, RT; Chirieac, LR; d'Amico, TA; Demmy, TL; Ganti, AK; Govindan, R; Grannis Jr, FW; Jahan, T; Jahanzeb, M; Johnson, DH; Kessinger, A; Komaki, R; Kong, FM; Kris, MG; Krug, LM; Le, QT; Lennes, IT; Martins, R; O'Malley, J; Osarogiagbon, RU; Otterson, GA; Patel, JD; Pisters, KM; Reckamp, K; Riely, GJ (2010). "Non-small cell lung cancer". Journal of the National Comprehensive Cancer Network : JNCCN 8 (7): 740–801. PMID 20679538.
    • for breast cancer, see Carlson, RW; Allred, DC; Anderson, BO; Burstein, HJ; Carter, WB; Edge, SB; Erban, JK; Farrar, WB; Goldstein, LJ; Gradishar, WJ; Hayes, DF; Hudis, CA; Jahanzeb, M; Kiel, K; Ljung, BM; Marcom, PK; Mayer, IA; McCormick, B; Nabell, LM; Pierce, LJ; Reed, EC; Smith, ML; Somlo, G; Theriault, RL; Topham, NS; Ward, JH; Winer, EP; Wolff, AC; NCCN Breast Cancer Clinical Practice Guidelines Panel (2009). "Breast cancer. Clinical practice guidelines in oncology". Journal of the National Comprehensive Cancer Network : JNCCN 7 (2): 122–92.PMID 19200416.
    • for colon cancer, see Engstrom, PF; Arnoletti, JP; Benson Ab, 3rd; Chen, YJ; Choti, MA; Cooper, HS; Covey, A; Dilawari, RA; Early, DS; Enzinger, PC; Fakih, MG; Fleshman Jr, J; Fuchs, C; Grem, JL; Kiel, K; Knol, JA; Leong, LA; Lin, E; Mulcahy, MF; Rao, S; Ryan, DP; Saltz, L; Shibata, D; Skibber, JM; Sofocleous, C; Thomas, J; Venook, AP; Willett, C; National Comprehensive Cancer Network (2009). "NCCN Clinical Practice Guidelines in Oncology: Colon cancer". Journal of the National Comprehensive Cancer Network : JNCCN7 (8): 778–831. PMID 19755046.
    • for other general statements see Smith, Thomas J.; Hillner, Bruce E. (2011). "Bending the Cost Curve in Cancer Care". New England Journal of Medicine 364(21): 2060–5. doi:10.1056/NEJMsb1013826.PMID 21612477. and Peppercorn, J. M.; Smith, T. J.; Helft, P. R.; Debono, D. J.; Berry, S. R.; Wollins, D. S.; Hayes, D. M.; Von Roenn, J. H.; Schnipper, L. E.; American Society of Clinical Oncology (2011). "American Society of Clinical Oncology Statement: Toward Individualized Care for Patients with Advanced Cancer".Journal of Clinical Oncology 29 (6): 755–60.doi:10.1200/JCO.2010.33.1744. PMID 21263086.
  43. Jump up^ "NCCN Guidelines".
  44. Jump up^ "Clinical Practice Guidelines for Quality Palliative Care"(PDF). The National Consensus Project for Quality Palliative Care (NCP).
  45. Jump up^ Levy MH, Back, A, Bazargan, S, Benedetti, C, Billings, JA, Block, S, Bruera, E, Carducci, MA, Dy, S, Eberle, C, Foley, KM, Harris, JD, Knight, SJ, Milch, R, Rhiner, M, Slatkin, NE, Spiegel, D, Sutton, L, Urba, S, Von Roenn, JH, Weinstein, SM, National Comprehensive Cancer Network (September 2006). "Palliative care. Clinical practice guidelines in oncology". Journal of the National Comprehensive Cancer Network: JNCCN 4 (8): 776–818. PMID 16948956.
  46. Jump up^ Waldmann, TA (March 2003). "Immunotherapy: past, present and future.". Nature Medicine 9 (3): 269–77.doi:10.1038/nm0303-269. PMID 12612576.
  47. Jump up^ Cassileth BR, Deng G (2004). "Complementary and alternative therapies for cancer". Oncologist 9 (1): 80–9.doi:10.1634/theoncologist.9-1-80. PMID 14755017.
  48. Jump up^ What Is CAM? National Center for Complementary and Alternative Medicine. retrieved 3 February 2008.
  49. Jump up^ Vickers A (2004). "Alternative cancer cures: 'unproven' or 'disproven'?". CA Cancer J Clin 54 (2): 110–8.doi:10.3322/canjclin.54.2.110. PMID 15061600.
  50. Jump up^ World Cancer Report 2014. World Health Organization. 2014. p. 22. ISBN 9283204298.
  51. ^ Jump up to:a b Rheingold, Susan; Neugut, Alfred; Meadows, Anna (2003). "156: Secondary Cancers: Incidence, Risk Factors, and Management". In Frei, Emil; Kufe, Donald W.; Holland, James F. Holland-Frei Cancer Medicine (6th ed.). Hamilton, Ont: BC Decker. p. 2399. ISBN 1-55009-213-8. Retrieved 5 November 2009.
  52. Jump up^ Montazeri A (December 2009). "Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008". Health Qual Life Outcomes 7: 102. doi:10.1186/1477-7525-7-102.PMC 2805623. PMID 20030832.
  53. Jump up^ Akl, EA; Kahale, LA; Ballout, RA; Barba, M; Yosuico, VE; van Doormaal, FF; Middeldorp, S; Bryant, A; Schünemann, H (10 December 2014). "Parenteral anticoagulation in ambulatory patients with cancer.". The Cochrane database of systematic reviews 12: CD006652.doi:10.1002/14651858.CD006652.pub4.PMID 25491949.
  54. Jump up^ "WHO Disease and injury country estimates". World Health Organization. 2009. Retrieved 11 November 2009.
  55. ^ Jump up to:a b Lozano, R; Mohsen, N; Foreman, K; Lim, S; Shibuya, K; Aboyans, V; Abraham, J; Adair, T; Aggarwal, R; Ahn, SY; AlMazroa, MA; Alvarado, M; Anderson, HR; Anderson, LM; Andrews, KG; Atkinson, C; Baddour, LM; Barker-Collo, S; Bartels, DH; Bell, ML; Benjamin, EJ; Bennett, D; Bhalla, K; Bikbov, B; Bin Abdulhak, A; Birbeck, G; Blyth, F; Bolliger, I; Boufous, S; Bucello, C (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet 380 (9859): 2095–128.doi:10.1016/S0140-6736(12)61728-0. PMID 23245604.
  56. Jump up^ WHO (October 2010). "Cancer". World Health Organization. Retrieved 5 January 2011.
  57. ^ Jump up to:a b Coleman, William B. and Rubinas, Tara C. (2009). "4". In Tsongalis, Gregory J. and Coleman, William L. Molecular Pathology: The Molecular Basis of Human Disease. Amsterdam: Elsevier Academic Press. p. 66. ISBN 0-12-374419-9.
  58. Jump up^ Johnson, George (28 December 2010). "Unearthing Prehistoric Tumors, and Debate". The New York Times.
  59. Jump up^ Pawelec G, Derhovanessian, E, Larbi, A (Aug 2010). "Immunosenescence and cancer". Critical reviews in oncology/hematology 75 (2): 165–72.doi:10.1016/j.critrevonc.2010.06.012. PMID 20656212.
  60. Jump up^ Alberts, B, Johnson A, Lewis J; et al. (2002). "The Preventable Causes of Cancer". Molecular biology of the cell (4th ed.). New York: Garland Science. ISBN 0-8153-4072-9. A certain irreducible background incidence of cancer is to be expected regardless of circumstances: mutations can never be absolutely avoided, because they are an inescapable consequence of fundamental limitations on the accuracy of DNA replication, as discussed in Chapter 5. If a human could live long enough, it is inevitable that at least one of his or her cells would eventually accumulate a set of mutations sufficient for cancer to develop.
  61. Jump up^ Anisimov VN, Sikora, E, Pawelec, G (Aug 2009). "Relationships between cancer and aging: a multilevel approach". Biogerontology 10 (4): 323–38.doi:10.1007/s10522-008-9209-8. PMID 19156531.
  62. Jump up^ de Magalhaes JP (2013). "How ageing processes influence cancer". Nature Reviews Cancer 13 (5): 357–65.doi:10.1038/nrc3497. PMID 23612461.
  63. Jump up^ Fraumeni, Joseph F.; Schottenfeld, David; Marshall, James M. (2006). Cancer epidemiology and prevention. Oxford [Oxfordshire]: Oxford University Press. p. 977.ISBN 0-19-514961-0.
  64. Jump up^ Bostwick, David G.; Eble, John N. (2007). Urological Surgical Pathology. St. Louis: Mosby. p. 468. ISBN 0-323-01970-6.
  65. ^ Jump up to:a b Kaatsch P, Sikora, E, Pawelec, G (June 2010). "Epidemiology of childhood cancer". Cancer treatment reviews 36 (4): 277–85. doi:10.1016/j.ctrv.2010.02.003.PMID 20231056.
  66. ^ Jump up to:a b Ward, Elizabeth; DeSantis, Carol; Robbins, Anthony; Kohler, Betsy; Jemal, Ahmedin (January 2014). "Childhood and adolescent cancer statistics, 2014". CA: A Cancer Journal for Clinicians 64: n/a–n/a.doi:10.3322/caac.21219. PMID 24488779.
  67. Jump up^ Ward EM, Thun, MJ, Hannan, LM, Jemal, A (Sep 2006). "Interpreting cancer trends". Annals of the New York Academy of Sciences 1076: 29–53.Bibcode:2006NYASA1076...29W.doi:10.1196/annals.1371.048. PMID 17119192.
  68. ^ Jump up to:a b c d e f Hajdu SI, Thun, MJ, Hannan, LM, Jemal, A (March 2011). "A note from history: landmarks in history of cancer, part 1". Cancer 117 (5): 1097–102.doi:10.1002/cncr.25553. PMID 20960499.
  69. Jump up^ Paul of Aegina, 7th Century AD, quoted in Moss, Ralph W. (2004). "Galen on Cancer". CancerDecisions. Archived from the original on 16 July 2011.[dead link] Referenced from Michael Shimkin, Contrary to Nature, Washington, D.C.: Superintendent of Document, DHEW Publication No. (NIH) 79-720, p. 35.
  70. Jump up^ Majno, Guido; Joris, Isabelle (August 12, 2004). Cells, Tissues, and Disease : Principles of General Pathology: Principles of General Pathology. Oxford University Press.ISBN 978-0-19-974892-1. Retrieved September 11, 2013.
  71. ^ Jump up to:a b Hajdu SI, Thun, MJ, Hannan, LM, Jemal, A (June 2011). "A note from history: landmarks in history of cancer, part 2". Cancer 117 (12): 2811–20.doi:10.1002/cncr.25825. PMID 21656759.
  72. Jump up^ Yalom, Marilyn (1998). A history of the breast (1st Ballantine Books ed.). New York: Ballantine Books. ISBN 0-679-43459-3.
  73. Jump up^ Hajdu SI, Thun, MJ, Hannan, LM, Jemal, A (July 2011). "A note from history: Landmarks in history of cancer, part 3".Cancer 118 (4): 1155–68. doi:10.1002/cncr.26320.PMID 21751192.
  74. Jump up^ Grange JM, Stanford JL, Stanford CA (2002). "Campbell De Morgan's 'Observations on cancer', and their relevance today". Journal of the Royal Society of Medicine 95 (6): 296–9. doi:10.1258/jrsm.95.6.296. PMC 1279913.PMID 12042378.
  75. Jump up^ Ehrenreich, Barbara (November 2001). "Welcome to Cancerland". Harper's Magazine. ISSN 0017-789X. Archived from the original on 6 July 2015.
  76. Jump up^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby.ISBN 1-4160-2999-0.
  77. Jump up^ "Skin cancers". World Health Organization. Retrieved19 January 2011.
  78. Jump up^ McCulley, Michelle; Greenwell, Pamela (2007). Molecular therapeutics: 21st-century medicine. London: J. Wiley. p. 207. ISBN 0-470-01916-6.
  79. Jump up^ Gwyn, Richard (1999). "10". In Cameron, Lynne; Low, Graham. Researching and applying metaphor. Cambridge, UK: Cambridge University Press. ISBN 0-521-64964-1.
  80. Jump up^ Sulik, Gayle (2010). Pink Ribbon Blues: How Breast Cancer Culture Undermines Women's Health. New York: Oxford University Press. pp. 78–89. ISBN 0-19-974045-3.OCLC 535493589.
  81. ^ Jump up to:a b c Olson, James Stuart (2002). Bathsheba's Breast: Women, Cancer and History. Baltimore: The Johns Hopkins University Press. pp. 145–170. ISBN 0-8018-6936-6.OCLC 186453370.
  82. ^ Jump up to:a b c d Ehrenreich, Barbara (2009). Bright-sided: How the Relentless Promotion of Positive Thinking Has Undermined America. New York: Metropolitan Books. pp. 15–44. ISBN 0-8050-8749-4.
  83. Jump up^ Huff, Charlotte (24 September 2013). "A Sick Stigma: Why are cancer patients blamed for their illness?". Slate.
  84. Jump up^ "Cancer Facts and Figures 2012". Journalist's Resource.org.
  85. Jump up^ "What Is Cancer?". National Cancer Institute. Retrieved17 August 2009.
  86. Jump up^ "Cancer Fact Sheet". Agency for Toxic Substances & Disease Registry. 30 August 2002. Retrieved 17 August2009.
  87. Jump up^ Wanjek, Christopher (16 September 2006). "Exciting New Cancer Treatments Emerge Amid Persistent Myths". Retrieved 17 August 2009.
  88. Jump up^ Hayden EC, Thun, MJ, Hannan, LM, Jemal, A (April 2009). "Cutting off cancer's supply lines". Nature 458 (7239): 686–687. doi:10.1038/458686b. PMID 19360048.
  89. Jump up^ Bagri, A; Kouros-Mehr, Hosein; Leong, KG; Plowman, GD (Mar 2010). "Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale.". Trends in molecular medicine 16(3): 122–32. doi:10.1016/j.molmed.2010.01.004.PMID 20189876.
  90. Jump up^ Sleigh SH, Barton CL (2010). "Repurposing Strategies for Therapeutics". Pharm Med 24 (3): 151–159.doi:10.2165/11536770-000000000-00000.
  91. Jump up^ Winther H, Jorgensen JT (2010). "Drug-Diagnostic Co-Development in Cancer". Pharm Med 24 (6): 363–375.doi:10.2165/11586320-000000000-00000.
  92. Jump up^ Sharon Begley (16 September 2008). "Rethinking the War on Cancer". Newsweek. Archived from the original on 10 September 2008. Retrieved 8 September 2008.
  93. Jump up^ Kolata, Gina (23 April 2009). "Advances Elusive in the Drive to Cure Cancer". The New York Times. Retrieved5 May 2009.
  94. Jump up^ Bruce Albertsa, Marc W. Kirschnerb, Shirley Tilghmanc, and Harold Varmus, Rescuing US biomedical research from its systemic flaws, Proceedings of the National Academy of Sciences of the United States of America, vol. 111 no. 16, April 2014
  95. Jump up^ Kolata, Gina (April 23, 2009). "Advances Elusive in the Drive to Cure Cancer". The New York Times. Retrieved2009-12-29.
  96. Jump up^ Kolata, Gina (June 27, 2009). "Grant System Leads Cancer Researchers to Play It Safe". The New York Times. Retrieved 2009-12-29.
  97. Jump up^ Leaf, Clifton (2004-03-22). "Why We're Losing The War On Cancer". Fortune Magazine (CNN Money).
  98. ^ Jump up to:a b c d e f g h i j Connie Henke Yarbro, Debra Wujcik, Barbara Holmes Gobel, ed. (2011). Cancer nursing: principles and practice (7 ed.). Jones & Bartlett Publishers. pp. 901–905. ISBN 978-1-4496-1829-2.
  99. Jump up^ Thamm, Douglas (March 2009). "How companion animals contribute to the fight against cancer in humans" (PDF).Veterinaria Italiana 54 (1): 111–120. Retrieved 18 July 2014.
  100. Jump up^ Murgia C, Pritchard JK, Kim SY, Fassati A, Weiss RA (August 2006). "Clonal origin and evolution of a transmissible cancer". Cell 126 (3): 477–87.doi:10.1016/j.cell.2006.05.051. PMC 2593932.PMID 16901782.
References
  • Holland, James F. (2009). Holland-Frei cancer medicine. (8th ed.). New York: McGraw-Hill Medical. ISBN 978-1-60795-014-1.
at January 28, 2016
Share:

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)
 
Toggle Footer